Log in
Enquire now
‌

US Patent 9241982 Purified plasmodium and vaccine compositions

Patent 9241982 was granted and assigned to Sanaria Inc. on January, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Sanaria Inc.
Sanaria Inc.
0
Current Assignee
Sanaria Inc.
Sanaria Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
92419820
Patent Inventor Names
Minglin Li0
B. Kim Lee Sim0
Richard E. Stafford0
Stephen L. Hoffman0
Date of Patent
January 26, 2016
0
Patent Application Number
146710030
Date Filed
March 27, 2015
0
Patent Citations Received
‌
US Patent 11883475 Infectious
0
Patent Primary Examiner
‌
Jennifer Graser
0
Patent abstract

Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9241982 Purified plasmodium and vaccine compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.